Form D — Absco Therapeutics, Inc.
0002023557-25-000004 · filed 2025-08-27
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $5,000,000
- Total sold
- $5,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Absco Therapeutics, Inc.
- CIK
- 2023557
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 127 WESTERN AVENUE
ALLSTON, MA 02134 - Phone
- 314-917-7620
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Stephen Linderman · Executive OfficerAllston, MA Find on LinkedIn ↗
-
Avik Som · DirectorAllston, MA Find on LinkedIn ↗
-
Carlo Giovanni Traverso · DirectorAllston, MA Find on LinkedIn ↗
View original on SEC EDGAR.